Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   MYLAN
EQUITY SHARE DATA
    SANOFI INDIA
Dec-23
MYLAN
Dec-18
SANOFI INDIA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs8,2783,967-   
Low Rs5,2402,184-   
Sales per share (Unadj.) Rs1,238.01,825.4-  
Earnings per share (Unadj.) Rs261.849.6-  
Cash flow per share (Unadj.) Rs279.0391.3-  
Dividends per share (Unadj.) Rs167.000-  
Avg Dividend yield %2.50-  
Book value per share (Unadj.) Rs411.21,974.7-  
Shares outstanding (eoy) m23.03514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.51.7 324.1%   
Avg P/E ratio x25.862.0 41.6%  
P/CF ratio (eoy) x24.27.9 308.3%  
Price / Book Value ratio x16.41.6 1,055.6%  
Dividend payout %63.80-   
Avg Mkt Cap Rs m155,6591,582,214 9.8%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m3,7060-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m28,511939,158 3.0%  
Other income Rs m6650-   
Total revenues Rs m29,176939,158 3.1%   
Gross profit Rs m8,203243,019 3.4%  
Depreciation Rs m396175,847 0.2%   
Interest Rs m1745,170 0.0%   
Profit before tax Rs m8,45522,002 38.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,426-3,500 -69.3%   
Profit after tax Rs m6,02925,502 23.6%  
Gross profit margin %28.825.9 111.2%  
Effective tax rate %28.7-15.9 -180.4%   
Net profit margin %21.12.7 778.7%  
BALANCE SHEET DATA
Current assets Rs m31,314524,425 6.0%   
Current liabilities Rs m25,347382,364 6.6%   
Net working cap to sales %20.915.1 138.4%  
Current ratio x1.21.4 90.1%  
Inventory Days Days15984 190.1%  
Debtors Days Days1793 18.1%  
Net fixed assets Rs m15,714182,181 8.6%   
Share capital Rs m230500 46.0%   
"Free" reserves Rs m9,2390-   
Net worth Rs m9,4691,015,998 0.9%   
Long term debt Rs m01,096,588 0.0%   
Total assets Rs m47,0282,725,301 1.7%  
Interest coverage x498.41.5 33,512.1%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.60.3 175.9%   
Return on assets %12.92.6 495.8%  
Return on equity %63.72.5 2,536.6%  
Return on capital %89.53.2 2,813.9%  
Exports to sales %18.00-   
Imports to sales %25.20-   
Net fx Rs m-2,0340-   
CASH FLOW
From Operations Rs m2,304195,157 1.2%  
From Investments Rs m375-100,875 -0.4%  
From Financial Activity Rs m-8,783-90,916 9.7%  
Net Cashflow Rs m-6,1041,617 -377.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare SANOFI INDIA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SANOFI INDIA With: ALBERT DAVID  SUVEN PHARMACEUTICALS  NUTRAPLUS PR  ALCHEMIST LIMITED  ANUH PHARMA  



Today's Market

Sensex Today Trades Flat | Nifty at 22,600 | Tech Mahindra Jumps 12% Sensex Today Trades Flat | Nifty at 22,600 | Tech Mahindra Jumps 12%(10:30 am)

Asian shares rose cautiously on Friday as markets sobered up to the idea that U.S. rate cuts were most likely some time away.